Polymorphisms in inflammation pathway genes and endometrial cancer risk
Delahanty, Ryan J., Xiang, Yong-Bing, Spurdle, Amanda, Beeghly-Fadiel, Alicia, Long, Jirong, Thompson, Deborah, Tomlinson, Ian, Yu, Herbert, Lambrechts, Diether, Dork, Thilo, Goodman, Marc T., Zheng, Ying, Salvesen, Helga B., Bao, Ping-Ping, Amant, Frederic, Beckmann, Matthias W., Coenegrachts, Lieve, Coosemans, An, Dubrowinskaja, Natalia, Dunning, Alison, Runnebaum, Ingo B., Easton, Douglas, Ekici, Arif B., Fasching, Peter A., Halle, Mari K., Hein, Alexander, Howarth, Kimberly, Gorman, Maggie, Kaydarova, Dylyara, Krakstad, Camilla, Lose, Felicity, Lu, Lingeng, Lurie, Galina, O'Mara, Tracy, Matsuno, Rayna K., Pharoah, Paul, Risch, Harvey, Corssen, Madeleine, Trovik, Jone, Turmanov, Nurzhan, Wen, Wanqing, Lu, Wei, Cai, Qiuyin, Zheng, Wei, & Shu, Xiao-Ou (2013) Polymorphisms in inflammation pathway genes and endometrial cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 22(2), pp. 216-223.
Experimental and epidemiologic evidence have suggested that chronic inflammation may play a critical role in endometrial carcinogenesis.
To investigate this hypothesis, a two-stage study was carried out to evaluate single-nucleotide polymorphisms (SNP) in inflammatory pathway genes in association with endometrial cancer risk. In stage I, 64 candidate pathway genes were identified and 4,542 directly genotyped or imputed SNPs were analyzed among 832 endometrial cancer cases and 2,049 controls, using data from the Shanghai Endometrial Cancer Genetics Study. Linkage disequilibrium of stage I SNPs significantly associated with endometrial cancer (P < 0.05) indicated that the majority of associations could be linked to one of 24 distinct loci. One SNP from each of the 24 loci was then selected for follow-up genotyping. Of these, 21 SNPs were successfully designed and genotyped in stage II, which consisted of 10 additional studies including 6,604 endometrial cancer cases and 8,511 controls.
Five of the 21 SNPs had significant allelic odds ratios (ORs) and 95% confidence intervals (CI) as follows: FABP1, 0.92 (0.85-0.99); CXCL3, 1.16 (1.05-1.29); IL6, 1.08 (1.00-1.17); MSR1, 0.90 (0.82-0.98); and MMP9, 0.91 (0.87-0.97). Two of these polymorphisms were independently significant in the replication sample (rs352038 in CXCL3 and rs3918249 in MMP9). The association for the MMP9 polymorphism remained significant after Bonferroni correction and showed a significant association with endometrial cancer in both Asian- and European-ancestry samples.
These findings lend support to the hypothesis that genetic polymorphisms in genes involved in the inflammatory pathway may contribute to genetic susceptibility to endometrial cancer. Impact statement: This study adds to the growing evidence that inflammation plays an important role in endometrial carcinogenesis.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.
|Item Type:||Journal Article|
|Keywords:||endometrial cancer, inflammation, genetic risk variants, meta-analysis|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200)
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2013 American Association for Cancer Research.|
|Deposited On:||12 Mar 2014 23:00|
|Last Modified:||14 Mar 2014 06:23|
Repository Staff Only: item control page